This inventor holds 1 USPTO granted patent and 9 published patent applications. Top assignee: Aconcagua Bio, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Ding Xue
Introduction
Ding Xue is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating conditions associated with calcitonin receptor and amylin receptor activity. His work is crucial in advancing medical treatments and improving patient outcomes.
Latest Patents
Ding Xue holds 1 patent for his innovative work titled "Compounds and compositions for treating conditions associated with calcitonin receptor and/or amylin receptor activity." This patent provides compounds for modulating calcitonin receptor and/or amylin receptor activity, along with pharmaceutical compositions that include these compounds. The methods outlined in the patent aim to treat diseases or disorders associated with these receptors, showcasing his commitment to addressing critical health issues.
Career Highlights
Ding Xue is currently associated with Aconcagua Bio, Inc., where he continues to push the boundaries of pharmaceutical research. His expertise in receptor activity modulation has positioned him as a key player in the industry, contributing to the development of innovative therapeutic solutions.
Collaborations
Ding Xue has collaborated with notable colleagues, including Hui Lei and Cui Li. These partnerships enhance the research environment and foster innovation within the pharmaceutical sector.
Conclusion
Ding Xue's contributions to the field of pharmaceuticals through his patent and collaborative efforts highlight his role as an influential inventor. His work not only advances scientific knowledge but also has the potential to improve the lives of many patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile